[junkie-button url=”https://infomeddnews.com” style=”grey” size=”medium” type=”round” target=”_blank”] HOME [/junkie-button]
The global peripheral vascular devices market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 Billion in 2017, at a CAGR of 6.8%.
Market growth is primarily driven by the growing incidence of peripheral vascular diseases, growing geriatric population, and increasing preference for minimally invasive surgeries.
The angioplasty stents segment is estimated to account for the largest market of the global peripheral vascular devices market in 2017.
The embolic protection devices segment is estimated to account for the largest share of the global hemodynamic flow alteration devices market. The large share of this segment can be attributed to the increasing number of peripheral vascular surgeries.
The guidewires segment is estimated to account for the largest share of other peripheral vascular devices market. The increasing use of guidewires in stenting procedures is the major factor driving the growth of this segment.
The global peripheral vascular devices market is dominated by North America, followed by Europe. North America will continue to dominate the global peripheral vascular devices market in the forecast period, however, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Factors such as the rising focus of major players in emerging Asia Pacific countries and government support is driving the growth of the peripheral vascular devices market in this region.
Factors such as the high degree of consolidation, the high cost of devices, and complex regulatory framework for the approval of new products may restrain market growth to a certain extent.
Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany) have been identified as key players in peripheral vascular devices market.
- Rapid Growth in the Aging Population And the Associated Increase in the Prevalence of Peripheral Vascular Diseases
- Product Approvals Are Fueling the Market Growth of Peripheral Vascular Devices
- Growing Preference for Minimally Invasive Surgery 39
- Product Failures And Recalls Are Hindering the Market Growth
- Emerging Markets Offers Lucrative Opportunities
- Availability of Alternative Treatments
- Abbott Laboratories
- B. Braun Melsungen
- Boston Scientific
- C. R. Bard
- Cordis (A Subsidiary of Cardinal Health)
For more information visit here.